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Despite the seminal definition for a clinician to consider a novel rehabilitation technique that
Krakauer and colleagues set nearly ten years ago, their attributes have remained timely and
appropriate [1]. They stated that the GAINS measured for the adoption of a novel
rehabilitation technique must be as good or better than those resulting from other treatments.
Further, the measured gains needed to PERSIST beyond treatment and then for an undefined
but “significant” period; clearly, they were suggesting strongly that the improvements
should be permanent. Also the measured gains needed to be demonstrated in untrained tasks;
namely, there should be evidence of GENERALIZATION of the improvements to other
tasks not involving direct training. Simply training for the test, an element central to many
arguments in modern teaching politics, would not qualify a novel rehabilitation technique.
To those clinically important parameters, we would add that the COST of the rehabilitation
technique should improve the current cost/benefit ratio of the current treatment. Knowing
that most rehabilitation units operate on a daily-capped cost basis, there is a continuing drive
to control costs even while delivering the most modern and effective treatment [1].
Taking advantage of Krakauer's crisp statement, we argue here that rehabilitation robotics
has met the stringent requirements and should be adopted as a novel rehabilitation
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technique. Our data have demonstrated efficacy and effectiveness for the interactive-robot
treatment of upper extremity (UE) weakness for patients who have experienced subacute
stroke [2, 3] and also those who sustained chronic stroke (see VA-Veterans Affairs’
ROBOTICS study and the employed robots in Figure 1) [4, 5]. It revealed that, in an era of
cost containment, introducing upper extremity robotics in a clinic did not increase the total
healthcare utilization costs. Active interventions add cost; for example, the extra cost of the
robotic equipment plus an additional therapist cost the VA $5,152 per patient. However,
when we compared the total cost, which included the clinical care needed to take care of
these Veterans, the robotic group cost less to the VA. The total healthcare utilization cost of
the usual-care group was $19,098 per patient, compared to $17,831 total healthcare cost for
the robotic group (including the additional cost of equipment and delivering robotic
therapy). To rule out any Hawthorne type effect, we requested the VA to continue collecting
healthcare utilization costs after the completion of the study. The data collected
demonstrated no placebo effect. In fact, the total healthcare cost for the robotic group went
down further after the completion of the study, perhaps because patients continued to
improve even without intervention [5]. This suggests in the “real” therapy world away from
the research environment that robotic therapy for the upper extremity offers better care for
the same or lower total cost. This result led the UK National Health Service (NHS) and its
Health Technology Assessment (HTA) Programme to embark in the largest ever RCT in
robotic therapy; the RCT plans to enroll between 720 and 800 stroke patients to determine
whether the same cost advantage can be observed in the British healthcare system (see
https://research.ncl.ac.uk/ratuls/).
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Furthermore, we have demonstrated that the gains measured by objective kinematic
measures [6, 7] reproducibly generalized to untrained tasks [8, 9]. These trials and a
multicenter randomized trial [4, 10] prompted the American Heart Association (AHA), the
Veterans Administration (VA) and Department of Defense (DOD) to endorse the use of
upper extremity robotics [11, 12].
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Although we predict that robotic training devices are destined to revolutionize standard
restorative neurology and physical medicine practices, robotics are not a general panacea for
stroke recovery; actually, for clinically effective training there should be a mandatory
number of movements per session and a number of sessions along the lines of the 10,000
hours of practice required to attain “expert athlete” levels of physical performance.
Interactive robots easily reach high levels of intensity, and it remains to be shown that
therapists, replicating the high intensity of robotic training, could achieve the same motor
outcome goals. In fact we recently showed that intensity-matched manually delivered
therapy could, in laboratory conditions, deliver 1,000 to-and-from movements per 45minutes of therapy session and achieve similar results (not practical in the clinical setting)
[13]. It allowed us to directly test whether the robot treated or therapist treated group
demonstrated comparable improvement in motor behavior. These results support the
effectiveness of high intensity training for the impaired limb and should banish forever the
therapy in standard care that averages 45 movement attempts per session [14]. Moreover, no
clinician or patient should expect a superior outcome with a low number of attempts to move
an affected limb delivered during robotic or usual care [15, 16]. Missing among these
clinical trials is mention of the fact that for nearly all of the patients who were 6 months or
Curr Phys Med Rehabil Rep. Author manuscript; available in PMC 2016 December 01.
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more after their acute stroke and who then received intensive robotic training, the
impairment was considered permanent and impervious to standard out-patient therapies, a
fact belied by novel intensive training programs [4].
That said, much remains to be done to improve outcomes further. To highlight the
variability of outcomes, notice the changes from admission to discharge in the VAROBOTICS study [4]:
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Of notice, a third of the patients improved over 5-points in the Fugl-Meyer assessment,
which corresponds to the minimal clinically important difference (MCID), a third of the
patients improved somewhat, and a third did not improve. Those studies raised new
questions focused on those patients who were mildly or completely resistant and the quest to
determine in short order who might be a responder, quasi-responder, and non-responder and
perhaps how to combine robotics with another intervention such as neuromodulation to
transform a non-responder into a responder.
The accumulated evidence for the effectiveness of robotic mediated rehabilitation led the
American Heart Association (AHA) to include endorsements for upper extremity (UE)
robotic therapy in their guidelines for the standard of post-stroke treatment. The
recommendation does not extend for the lower extremity (LE), stating that “most trials of
robot-assisted motor rehabilitation concern the UE, with robotics for the LE still in its
infancy…” [11]. The Veterans Administration similarly endorsed robotic therapy for UE but
not for LE: “recommendation is made against routinely providing the [LE] intervention…
At least fair evidence was found that the intervention is ineffective …” [12]. The AHA and
VA recommendations compared robotic outcomes with usual care as practiced in the US.
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One first step to remedy this situation is to distinguish between “best practices” and tested
practices. Clinicians have operated on the assumption that body-weight-supported treadmill
(BSWTT) training delivered by 2 or 3 therapists per stroke patient was “best practice” and
superior to the usual care. Thus, automating BWSTT appeared to be logical. However, an
NIH-sponsored clinical trial, Locomotor Experience Applied Post-Stroke (LEAPS)
demonstrated that BSWTT did not lead to results superior to those from a home program
with only strength and balance training [17]. This result was contrary to the hypothesis of its
clinical proponents. The goal of rehabilitation robotics cannot be to simply automate current
rehabilitation practices as, for the most part, they lack evidential basis: a scientific basis is
needed for development of effective robotic therapy. In order words, existing robotic tools
that represent a robotic embodiment of BWSTT train only a subset of the required aspects
for normal gait and hence, a direct comparison robotic versus usual care as practiced in the
US led to negative outcomes [18, 19].
The landmark LEAPS study must be seriously considered by both roboticists and clinicians:
it did not demonstrate superiority of BWSTT for either severe or moderate stroke patients.
While many studies of robotic embodiments of BWSTT compared to usual care as practiced
outside the US (varied levels of usual care) were more positive[20], we continue to be
highly optimistic that with careful research we can improve outcomes for LE, possibly
expanding the tools and training approaches to include other aspects of gait and balance.
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Fig. 1. A Gym of Upper Extremity Robots
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Top row, left shows a person with chronic stroke working with the anti-gravity shoulderand-elbow robot. The top row, middle panel shows a person working with the planar
shoulder-and-elbow robot. The top row, right panel shows the wrist robot during therapy at
the Burke Rehabilitation Hospital. The lower row, left panel shows the hand module for
grasp and release. The lower row, middle panel shows reconfigurable robots. The robotic
therapy shoulder-and-elbow and wrist modules can operate in standalone mode or be
integrated into a coordinated functional unit. The lower row, right panel shows the shoulderand-elbow and hand module integrated into a coordinated functional unit.
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Fig. 2. VA-ROBOTICS Multi-Site Trial: Individual Patient’s Change in Score and
Randomization Date

Figure shows the results of the 3 groups of chronic stroke patients: black circles = usual care
(UC), blue diamond = robot training group (RT), red squares = intensive comparison
training group (ICT). UC received 3 therapy sessions focused on the upper extremity,
average of 45 movement attempts per session. RT and ICT received 3 therapy sessions per
week focused on the upper extremity, average of 1,024 movement attempts per session. The
robot and intensive care therapy group demonstrated a significant reduction in impairment
and disability and significant gains in quality of life scores as compared to usual care.
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